Canada

December 10, 2020December 10, 2020

Canada Approves Lynparza for Metastatic CRPC Patients With Certain Gene Mutations

News

Canadian authorities have approved Lynparza (olaparib) as an oral treatment for people with metastatic castration-resistant prostate cancer (mCRPC) who carry mutations in BRCA or ATM genes, both of which are involved in ... Read more

February 28, 2018March 1, 2018

Consuming Alcohol After Prostate Cancer Diagnosis is Detrimental, Canadian Study Says

News

Alcohol consumption after prostate cancer diagnosis is associated with reduced prostate cancer-specific survival, specifically in men who consume more than two drinks per day, according to a Canadian study. The ... Read more

November 7, 2017

November is Tied to ‘Bowvember’ for Prostate Cancer Awareness in Canada

News

In celebration of Prostate Cancer Awareness Month in Canada this November, the nonprofit Procure has teamed up with fashion designer Philippe Dubuc to create the 2017 bow tie, as the 4th ... Read more

October 1, 2014October 1, 2014

Canada Launches Six-Month Dosing of Trelstar for Prostate Cancer Patients

News

A new six-month dosing option (22.5 mg) dosage of Trelstar (triptorelin pamoate), a drug indicated for the palliative treatment of hormone dependent advanced prostate cancer, is now available in Canada. ... Read more